Binding of Translationally Controlled Tumour Protein to the N-terminal domain of HDM2 is inhibited by nutlin-3.
Translationally Controlled Tumour Protein (TCTP), a highly conserved protein present in all eukaryotic organisms, has a number of intracellular and extracellular functions including an anti-apoptotic role. TCTP was recently shown to interact with both p53 and HDM2, inhibiting auto-ubiquitination of...
Main Authors: | Garth Funston, Walter Goh, Siau Jia Wei, Quah Soo Tng, Christopher Brown, Loh Jiah Tong, Chandra Verma, David Lane, Farid Ghadessy |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3418249?pdf=render |
Similar Items
-
Inhibition of nutlin-resistant HDM2 mutants by stapled peptides.
by: Siau Jia Wei, et al.
Published: (2013-01-01) -
In vitro selection of mutant HDM2 resistant to Nutlin inhibition.
by: Siau Jia Wei, et al.
Published: (2013-01-01) -
Structure of a stapled peptide antagonist bound to nutlin-resistant Mdm2.
by: Sharon Min Qi Chee, et al.
Published: (2014-01-01) -
HDM2 antagonist MI-219 (spiro-oxindole), but not Nutlin-3 (<it>cis</it>-imidazoline), regulates p53 through enhanced HDM2 autoubiquitination and degradation in human malignant B-cell lymphomas
by: Sosin Angela M, et al.
Published: (2012-09-01) -
Nutlin3a Contributes to the Cytoplasmic Retention of Androgen Receptor
by: Gulseren Ozduman, et al.
Published: (2018-12-01)